TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma

SIMPLE SUMMARY: Most patients with glioblastoma (GBM) develop recurrent diseases which can be treated with different approaches. Given the aggressive and resilient nature of GBM, continued efforts to better understand GBM pathophysiology are required to discover novel targets for future therapy. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Campolo, Michela, Lanza, Marika, Casili, Giovanna, Paterniti, Irene, Filippone, Alessia, Caffo, Maria, Cardali, Salvatore M., Puliafito, Ivana, Colarossi, Cristina, Raciti, Gabriele, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794959/
https://www.ncbi.nlm.nih.gov/pubmed/33375627
http://dx.doi.org/10.3390/cancers13010041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794959/
https://www.ncbi.nlm.nih.gov/pubmed/33375627
http://dx.doi.org/10.3390/cancers13010041

Ejemplares similares